Coverage is the key for effective screening of Chlamydia trachomatis in Australia

Journal of Infectious Diseases

Volumn 198, Issue 3, 2008, Pages 349-358

  Regan, David G ^a   Wilson, David P ^a   Hocking, Jane S ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BACTERIAL TRANSMISSION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONDOM; DIAGNOSTIC TEST; DISEASE DURATION; EPIDEMIC; FEMALE; HUMAN; MALE; NORMAL HUMAN; PARAMETER; PREVALENCE; PRIORITY JOURNAL; SCREENING; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SEXUAL BEHAVIOR;

ADOLESCENT; ADULT; AGE FACTORS; AUSTRALIA; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; LYMPHOGRANULOMA VENEREUM; MALE; MASS SCREENING; MIDDLE AGED; MODELS, STATISTICAL; PREVALENCE; SEX FACTORS; SEXUAL BEHAVIOR; TIME FACTORS;

EID: 48749104191     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/589883     Document Type: Article

References (43)

1. Australia. Department of Health and Ageing. National Notifiable Diseases Surveillance System. Number of notifications of Chlamydial infection, Australia, 2007 by age group and sex. Available at: http://www9.health.gov.au/cda/Source/ CDA-index.cfm. Accessed 10 June 2008.
2. Vajdic CM, Middleton M, Bowden FJ, Fairley CK, Kaldor JM. The prevalence of genital Chlamydia trachomatis in Australia 1997-2004: a systematic review. Sex Health 2005; 2:169-83.
3. Peipert JF. Genital chlamydial infections. N Engl J Med 2003; 349:2424-30.
4. Lau C-Y, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomised clinical trials. Sex Transm Dis 2002; 29:497-502.
5. Egger M, Low N, Smith GD, Lindblom B, Herrmann B. Screening for chlamydia infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ 1998; 316:1776-80.
6. Herrmann B, Egger M. Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985-1993: declining rates for how much longer? Sex Transm Dis 1995; 22:253-60.
7. Kamwendo F, Forslin L, Bodin L, Danielsson D. Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease: a 25-year study from an urban area of central Sweden. Sex Transm Dis 1996; 23:384-91.
8. LaMontagne DS, Fenton KA, Randall S, Anderson S, Carter P. Establishing the national chlamydia screening programme in England: results from the first full year of screening. Chlamydia Screening Steering Group. Sex Transm Infect 2004; 80:335-41.
9. Abbott T. Pilot testing program for chlamydia [media release ABB078/05]. Australian Department of Health and Ageing, 2005.
10. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. New York: Oxford University Press, 1991.
11. Diekmann O, Heesterbeek JAP. Mathematical epidemiology of infectious diseases: model building, analysis and interpretation. Chichester, UK: Wiley, 2000.
12. Jacquez JA. Compartmental analysis in biology and medicine. 3rd ed. Ann Arbor, MI: BioMedware, 1996.
13. Smith AMA, Rissel CE, Richters J, Grulich AE, de Visser RO. Australian study of health and relationships. Aust NZ J Public Health 2003; 27:103-256.
14. Australian Bureau of Statistics. Population by age and sex, Australia. Catalogue no. 3235.0. Available at: http://www.abs.gov.au/AUSSTATS/abs@.nsf/ DetailsPage/3235.02006?OpenDocument. Accessed 10 June 2008.
15. Quinn TC, Gaydos C, Shepherd M, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996; 276:1737-42.
16. Kretzschmar M, Welte R, van den Hoek A, Postma MJ. Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol 2001; 153:90-101.
17. Kretzschmar M, van Duynhoven YT, Severijinen AJ. Modeling prevention strategies for gonorrhea and chlamydia using stochastic network simulations. Am J Epidemiol 1996; 144:306-17.
18. Sutton T, Martinko T, Hale S, Fairchok M. Prevalence and high rate of asymptomatic infection of Chlamydia trachomatis in male college research training corps cadets. Sex Transm Dis 2003; 30:901-4.
19. McKay L, Clery H, Carrick-Anderson K, Hollis S, Scott G. Genital Chamydia trachomatis infection in a subgroup of young men in the UK. Lancet 2003; 361:1792.
20. Farley TA, Cohen D, Elkins W. Asymptomatic sexually transmitted diseases: the case for screening. Prev Med 2003; 36:502-9.
21. Morre SA, van den Brule AJC, Rozendaal L, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow up. Int J STD AIDS 2002; 13:12-8.
22. Molano M, Meijer CJLM, Weiderpass E, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis 2005; 191:907-16.
23. Morre SA, Sillekens P, Jacobs M, et al. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification. Mol Path 1998; 51:149-54.
24. Cook RL, Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005; 142:914-25.
25. Australia. Health Insurance Commission. Medicare item 69369 processed from January 2003 to December 2003, and Medicare item 69370 processed from January 2003 to December 2003. Available at: https://www.medicareaustralia.gov. au/statistics/mbs_item.shtml. Accessed 10 June 2008.
26. Chen MY, Ryder N, Donovan B. Completeness and timeliness of treatment for chlamydia within a sexual health service. Int J STD AIDS 2004; 15:762-4.
27. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005; 192:1836-44.
28. Australia. Department of Health and Ageing. National Sexually Transmissible Infections Strategy 2005-2008. Available at: http://www.health. gov.au/internet/wcms/publishing.nsf/Content/phd-sti-strategy-cnt.htm/ $FILE/sti_strategy.pdf. Accessed 10 June 2008.
29. Hocking J, Willis J, Tabrizi S, Hellard M, Garland S, Fairley CK. A chlamydia prevalence survey of young women living in Melbourne, Victoria. Sex Health 2006; 3:235-40.
30. Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. Int Stat Rev 1994; 62:229-43.
31. Fedra K, van Straten G, Beck MB. Uncertainty and arbitrariness in ecosystems modeling: a lake modeling example. Ecol Model 1981; 13:87-110.
32. Rose KA, Smith EP, Gardner RH, Brenkert AL, Bartell SM. Parameter sensitivities, Monte Carlo filtering, and model forecasting under uncertainty. J Forecasting 1991; 10:117-33.
33. Australia. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2006. Available at: http://www.nchecr.unsw.edu.au/ NCHECRweb.nsf/resources/SurvReports_4/$file/06_ansurans_rev.pdf. Accessed 10 June 2008.
34. Gold J, Hocking J, Hellard M. The feasibility of recruiting young men in rural areas from community football clubs for STI screening. Aust NZ J Public Health 2007; 31:243-46.
35. Australia. Medicare Australia. Number of women and men aged 15 to 24 years who had an unreferred attendance at a GP in 2004, 2005.
36. Australia. Australian Institute of Health and Welfare. Cervical screening in Australia 2004-2005. Cancer series no. 38. Catalogue no. CAN 33. Canberra: AIHW. Available at: http://www.aihw.gov.au/publications/index.cfm/title/10457. Accessed 10 June 2008.
37. Turner KM, Adams EJ, Lamontagne DS, Emmett L, Baster K, Edmunds WJ. Modelling the effectiveness of chlamydia screening in England. Sex Transm Infect 2006;82:496-502.
38. Goètz H, Lindbaèck J, Rips T, Arneborn M, Ramstedt K, Ekdahl K. Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods? Scand J Infect Dis 2002; 34:28-34.
39. Low N, Egger M. What should we do about screening for genital chlamydia? Int J Epidemiol 2002; 31:891-3.
40. Burstein GR, Gaydos CA, Diener-West M, Howell MR, Zenilman JM, Quinn TC. Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA 1998; 280:521-6.
41. Bradshaw CS, Pierce LI, Tabrizi SN, Fairley CK, Garland SM. Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling. Sex Transm Infect 2005; 81:53-8.
42. Morton AN, Wakefield T, Tabrizi SN, Garland SM, Fairley CK. An outreach programme for sexually transmitted infection screening in street sex workers using self-administered samples. Int J STD AIDS 1999; 10:741-3.
43. Williams H, Tabrizi SN, Lee W, Kovacs GT, Garland S. Adolescence and other risk factors for Chlamydia trachomatis genitourinary infection in women in Melbourne, Australia. Sex Transm Infect 2003; 79:31-4.